HOME >> BIOLOGY >> NEWS
TIGR completes study providing insight into infectious strain of bacterium that causes otitis, pneumonia and meningitis

ROCKVILLE, MD Investigators at The Institute for Genomic Research (TIGR) today announced that they have determined the complete genome sequence of a virulent isolate (a very infectious strain) of Streptococcus pneumoniae or pneumococcus, the bacterium which causes over 3 million children and even more elderly people to die every year from pneumonia or meningitis. It is also the most common cause of otitis media or ear infection.

Herv Tettelin, Ph.D., principal investigator for the project, led the team at TIGR that determined the order of all of the 2.16 million individual chemical base units making up S. pneumoniaes DNA. This study, reported in the July 20 issue of Science, represents the 26th genome sequencing project completed by TIGR.

S. pneumoniae is one of the most significant bacterial pathogens of humans in terms of morbidity and mortality and this situation is compounded by a progressive increase in antibiotic resistance, particularly to penicillin and to other commonly used antibiotics, that has been observed worldwide. This increased resistance complicates the ability to treat pneumococcal infections and is focusing greater attention on prevention strategies. Undoubtedly, the availability of the complete genome sequence will provide additional avenues for follow-up studies on the basic biology and pathogenicity of this important pathogen.

Genome analysis revealed a number of novel insights relevant to the biology of S. pneumoniae including: the observation that 5% of the genome is composed of repeats (pieces of DNA that are found in several locations in the genome) that may facilitate incorporation of foreign DNA into the S. pneumoniae chromosome and contribute to rearranging its structure; the description of a new sequence motif that may be involved in bringing proteins to the surface of the bacteria, including virulence factors and a novel large protein composed of 540 repeat modules that could play a role in adhesion to huma
'"/>

Contact: Sharon Dukes
sdukes@tigr.org
301-610-5969
The Institute for Genomic Research
19-Jul-2001


Page: 1 2

Related biology news :

1. OneWorld Health completes enrollment, treatment in Phase III India trial
2. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
3. NTP completes 500th two-year rodent study and report; series is the gold standard of animal toxicology
4. DoubleTwist completes the first annotation of the human genome
5. Student science contest participation influences study, career choices, alumni say
6. New study shows hope for treating inhalant abuse
7. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
8. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
9. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
10. Phase II trials of second-generation antisense cancer drug planned following successful early study
11. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... ... John R. Freeman, CPA, has joined BioLabs as Chief Financial Officer. His ... provides premier co-working spaces for life science startups in the most dynamic biotech hubs. ... growth,” says Fruehauf. “BioLabs has expanded to 10 locations in just a few years, ...
(Date:8/1/2019)... ... July 31, 2019 , ... Advancements with Ted Danson ... for more information. , Factor Bioscience Inc. (Factor) is pioneering nucleic-acid and cell-based ... diseases. This segment of Advancements will explore how Factor Bioscience is building the ...
(Date:7/26/2019)... , ... July 25, 2019 , ... ... announced the first mixed reality headsets to include a new generation eye tracker ... Exhibition in Los Angeles, California (July 30 - August 1). SIGGRAPH attendees ...
Breaking Biology News(10 mins):
(Date:8/14/2019)... ... August 13, 2019 , ... INDIGO Biosciences, ... testing solutions, announced the appointment of Mark McLoughlin to the Company’s Board of ... Mark McLoughlin will lend his healthcare expertise and extensive background in laboratory and ...
(Date:8/6/2019)... ... August 06, 2019 , ... The San ... in launching the biweekly SDBN BUZZ podcast focused on connecting the region’s biotech ... also serve to promote the region and attract external employers, investors, scientists, and ...
(Date:8/4/2019)... MINNEAPOLIS (PRWEB) , ... August 02, 2019 , ... Cirtec ... minimally invasive devices, today announced that it has begun construction on a 30,000 sq. ... about 15 miles from San Jose. , The facility, which is expected to ...
(Date:7/19/2019)... ... July 18, 2019 , ... Global precision ... enlarge their current piezo motion facilities in Lederhose, Germany, increasing their current footprint ... piezo ceramic assembly production in addition to general office space, a significant increase ...
Breaking Biology Technology:
Cached News: